Open AccessPreoperative 18F-FDG PET/CT in Pheochromocytomas and Paragangliomas Allows for Precision Surgery
Author(s) -
Pavel Nockel,
Mustapha El Lakis,
Apostolos Gaitanidis,
Roxanne Merkel,
Dhaval Patel,
Naris Nilubol,
Tamara Prodanov,
Karel Pacák,
Electron Kebebew
Publication year - 2019
Publication title -
annals of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.153
H-Index - 309
eISSN - 1528-1140
pISSN - 0003-4932
DOI - 10.1097/sla.0000000000002671
Subject(s) - medicine , pheochromocytoma , positron emission tomography , paraganglioma , radiology , fluorodeoxyglucose , nuclear medicine , preoperative care , surgery , pathology
Fluorodeoxyglucose (F-FDG) positron emission tomography/computed tomography (PET/CT) imaging is recommended in patients with metastatic pheochromocytoma (PC) and paraganglioma (PGL). There are no data on whether routine preoperative F-FDG PET/CT in all patients with PC/PGL impacts surgical management.